FFCP PHASE1:Hg19::chr2:113522248..113522259,-
From FANTOM5_SSTAR
Jump to: navigation, search
Short description: | p2@CKAP2L |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_2_at_CKAP2L_5end |
Coexpression cluster: | C109_Reticulocytes_non_acute_Hodgkin_Burkitt_retinoblastoma_lymphoma |
Association with transcript: | 0bp_to_ENST00000302450, NM_152515, uc002tie.2, uc002tif.2, uc010yxp.1, uc010yxq.1_5end |
EntrezGene: | 150468 |
HGNC: | 26877 |
UniProt: | Q8IYA6 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p2@CKAP2L |
---|
0
2
4
6
8
10
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
cancer | 3.40e-35 | 235 |
disease of cellular proliferation | 9.83e-34 | 239 |
organ system cancer | 3.97e-20 | 137 |
cell type cancer | 7.84e-18 | 143 |
carcinoma | 2.60e-15 | 106 |
hematologic cancer | 2.25e-14 | 51 |
immune system cancer | 2.25e-14 | 51 |
leukemia | 2.93e-13 | 39 |
myeloid leukemia | 8.16e-09 | 31 |
squamous cell carcinoma | 3.76e-08 | 14 |
Showing 1 to 10 of 12 entries